AI Health Tools: Reading Performance Evidence as a Governance Artifact
The performance evidence generated by AI health tools is not merely a collection of metrics. It is a critical governance artifact. For governance committees and…
The performance evidence generated by AI health tools is not merely a collection of metrics. It is a critical governance artifact. For governance committees and…
The pathway to FDA clearance for an AI-powered medical device is a well-trodden, if complex, road. Yet, achieving regulatory approval for the device itself does…
A clearance decision for an AI-powered medical device is a significant milestone, but it is not the finish line. For compliance and quality leads, it…
Companies working through the complex field of AI in healthcare face a critical juncture: either establish a clear, FDA-compliant Software as a Medical Device (SaMD)…
Hello Heart shows how SaMD delivers personalized insights for chronic disease management without replacing clinicians. Learn how FDA rules protect patients.
Patients overwhelmed by health info? Pathway explainers reduce anxiety, improve understanding, and cut follow-up questions by 10%.
The rapid infusion of generative AI into clinical workflows, particularly through integrations with major Electronic Health Record (EHR) systems, presents an unprecedented challenge for regulators.…
The field of digital health regulation is in constant flux, a dynamic environment where technological innovation frequently outpaces established legal frameworks. The FDA’s ambitious Digital…
The field for connected Software as a Medical Device (SaMD) has shifted dramatically, elevating cybersecurity from a best practice to a foundational regulatory mandate. Companies…
The global ambition for AI-powered health tools often collides with the intricate realities of regulatory divergence. For product managers, digital health executives, and international regulatory…